The Biomarker Multiplexing Capabilities Of LC-MS Technology

January 6th, 2021|0 Comments

Metabolomic Diagnostics is delighted to announce that CEO Robin Tuytten will present "The Biomarker Multiplexing Capabilities Of LC-MS Technology: The Key to Unlock Personalised Preeclampsia Risk Prediction Early in Pregnancy" for the American Association for Clinical [...]

Metabolomic Diagnostics appoints a new CEO and announces new funding

November 3rd, 2020|0 Comments

Metabolomic Diagnostics Little Island Cork, Ireland Metabolomic Diagnostics, the Ireland based deep tech medical diagnostics company, today announced the completion of a further venture capital funding round and the appointment of Dr. Robin Tuytten to [...]

Join our Science Team

September 15th, 2020|0 Comments

  SENIOR SCIENTIST MASS SPECTROMETRIST  BIOMARKER VERIFICATION AND VALIDATION Project/Job Description Metabolomic Diagnostics Ltd is an early stage biotechnology company located in Cork, Ireland. The company is developing novel and innovative tests to predict pregnancy [...]


Attendance at SDMD Global 2020

February 7th, 2020|1 Comment

Attendance at SDMD Global 2020 Mr. Diarmuid Cahalane, Co-Founder & Director of Regulatory Affairs, Metabolomic Diagnostics will present at Software Design for Medical Devices Global (SDMD) forum in Berlin (17th -20th Feb 2020).    This [...]


January 28th, 2020|0 Comments

Mr Charles Garvey, CEO of Metabolomic Diagnostics will be attending the Society of Maternal Fetal Medicine (SMFM) Pregnancy meeting next week in Texas, USA. The SMFM is a non-profit, membership organisation based in the [...]


October 8th, 2019|0 Comments

Metabolomic Diagnostics are excited to be part of Med In Ireland this Thursday, 10th October at the RDS, Dublin Organised by Enterprise Ireland, Med in Ireland brings together innovative Irish medtech companies with healthcare providers [...]

EuroISHHP Conference 2019, Lund, Sweden

September 27th, 2019|0 Comments

Metabolomic Diagnostics are proud to sponsor the European International Society of the Study of Hypertension in Pregnancy (ISHHP) in Lund, Sweden next week. The theme of this year’s conference is “Thinking out of the box”. [...]

Codex4SMEs, Galway

September 18th, 2019|0 Comments

Mr. Diarmuid Cahalane, Co-Founder & Director of Metabolomic Diagnostics was one of the key speakers at the European Union, Interreg Project CODEX4SMEs conference in Galway last week.   WestBIC, CÚRAM and their European partners hosted [...]

Metabolomic Diagnostics to attend MSACL, Salzburg

September 17th, 2019|0 Comments

The Association for Mass Spectrometry Applications to the Clinical Lab (MSACL) 6th European meeting will take place in Salzburg, Austria later this month. MSACL provides a forum for discussing the clinical application of mass spectrometry [...]

Metabolomic Diagnostics QMS Certified to ISO 13485:2016

April 18th, 2019|0 Comments

CORK, Ireland April 19th, 2019. Metabolomic Diagnostics has today announced that its Quality Management system has successfully transitioned from ISO 13485: 2012 to ISO 13485:2016 following an audit by Certification Body, BQAI. This certification indicates [...]